Mati Therapeutics' Unattributed - III Round

Mati Therapeutics raised a round of funding on October 16, 2018.

Mati Therapeutics is developing a platform to provide sustained drug delivery to the surface of the eye.…

Articles about Mati Therapeutics' Unattributed - III Round: